Charles J Knight1, Adam D Timmis. Show Affiliations » 1. Barts and the London School of Medicine and Dentistry, London Chest Hospital, UK. Charles.Knight@bartsandthelondon.nhs.uk
Abstract
Entities: Disease
Mesh： See more » Acute Coronary Syndrome/bloodAcute Coronary Syndrome/diagnosisAcute Coronary Syndrome/epidemiologyAcute Coronary Syndrome/therapyAngioplasty, Balloon, CoronaryAntifibrinolytic Agents/therapeutic useBiomarkers/bloodCardiology/trendsDrug Therapy, CombinationEvidence-Based MedicineGlobal HealthHumansIncidenceLife StylePeriodicals as TopicPlatelet Aggregation Inhibitors/therapeutic usePractice Guidelines as TopicPredictive Value of TestsRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsSensitivity and SpecificityStentsSurvival RateThrombectomyTroponin I/bloodUnited Kingdom/epidemiology
Substances： See more » Antifibrinolytic AgentsBiomarkersPlatelet Aggregation InhibitorsTroponin I
Year: 2011 PMID： 21948961 DOI： 10.1136/heartjnl-2011-300979
Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994